Skip to main content

Published locations for FDA approves omalizumab for chronic idiopathic urticaria

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves omalizumab for chronic idiopathic urticaria

User login

  • Reset your password
  • /content/fda-approves-omalizumab-chronic-idiopathic-urticaria
  • /edermatologynews/article/81116/dermatology/fda-approves-omalizumab-chronic-idiopathic-urticaria
  • /familypracticenews/article/81116/dermatology/fda-approves-omalizumab-chronic-idiopathic-urticaria
  • /internalmedicinenews/article/81116/dermatology/fda-approves-omalizumab-chronic-idiopathic-urticaria
  • /pediatricnews/article/81116/dermatology/fda-approves-omalizumab-chronic-idiopathic-urticaria
  • /pulmonary-health-hub/article/81116/dermatology/fda-approves-omalizumab-chronic-idiopathic-urticaria
  • /pediatrics/article/81116/dermatology/fda-approves-omalizumab-chronic-idiopathic-urticaria
  • /internalmedicine/article/81116/dermatology/fda-approves-omalizumab-chronic-idiopathic-urticaria
  • /dermatology/article/81116/dermatology/fda-approves-omalizumab-chronic-idiopathic-urticaria
  • /familymedicine/article/81116/dermatology/fda-approves-omalizumab-chronic-idiopathic-urticaria